|
A behavioral trial for parents of childhood cancer survivors with neurobehavioral
|
1R03CA130731-01A1
|
$83,250
|
Patel, Sunita
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent or
|
Z01 BC 010585
|
$23,122
|
Warren, Katherine
|
CCR (NCI)
|
|
ABC Transporters in Human Disease and Multidrug Resistance
|
Z01 BC 005725
|
$579,181
|
Dean, Michael
|
CCR (NCI)
|
|
ALARA Meeting
|
Z01 CP010131-10444
|
$19,805
|
Ron, Elaine
|
DCEG (NCI)
|
|
American College of Radiology Imaging Network
|
2U01CA080098-10
|
$9,101,961
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap
|
Z01 BC 010709
|
$92,488
|
Warren, Katherine
|
CCR (NCI)
|
|
Analyses of the Molecular Functions for D-Cyclins
|
5R01CA108420-05
|
$340,435
|
SICINSKI, PIOTR
|
DANA-FARBER CANCER INSTITUTE
|
|
Analysis of the VHL-HIF hydroxylase pathway
|
5R01CA125020-02
|
$221,920
|
SHIIO, YUZURU
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Analyzing Myc function in neural cancers and development
|
5K01CA114400-04
|
$154,780
|
Knoepfler, Paul
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Anticancer Drug Development for Childhood Cancers
|
Z01 SC 006880
|
$842,657
|
Balis, Frank
|
CCR (NCI)
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S5
|
$3,963,721
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S6
|
$100,000
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA
|
Z01 BC 011002
|
$122,346
|
Khan, Javed
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
Z01 BC 011098
|
$1,538,748
|
Fine, Howard
|
CCR (NCI)
|
|
Brain tumor family study of genetic susceptibility and environmental factors
|
Z01 CP005803-08050
|
$5,408
|
Goldstein, Alisa
|
DCEG (NCI)
|
|
Breast implant follow-up study
|
Z01 CP010128-01220
|
$31,576
|
Brinton, Louise
|
DCEG (NCI)
|
|
Cancer Center Support (Core) Grant
|
2P30CA016672-33
|
$10,542,275
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-33S1
|
$124,410
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
2P30CA013696-35
|
$3,785,244
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
2P30CA008748-43
|
$13,879,527
|
VARMUS, HAROLD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Center Support Grant
|
3P30CA008748-43S1
|
$144,142
|
VARMUS, HAROLD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Center Support Grant
|
3P30CA046934-21S1
|
$728,250
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
3P30CA046934-21S2
|
$73,150
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
3P30CA046934-21S3
|
$85,992
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
5P30CA046934-21
|
$3,604,774
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
3P30CA044579-18S1
|
|
WEBER, MICHAEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Cancer Center Support Grant
|
3P30CA044579-18S2
|
$96,993
|
WEBER, MICHAEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Cancer Center Support Grant
|
5P30CA044579-18
|
$2,410,577
|
WEBER, MICHAEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Cancer Center Support Grant (CCSG)
|
2P30CA021765-30
|
$5,937,934
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-30S1
|
$50,000
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Children's Oncology Group Chair's Grant
|
2U10CA098543-06
|
$31,493,718
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-06S1
|
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-06S2
|
$18,805
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-06S3
|
$750,000
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
2U10CA098413-06
|
$5,717,149
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Chromosomal Proteins and Chromosomal Functions
|
Z01 BC 004496
|
$1,045,139
|
Bustin, Michael
|
CCR (NCI)
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
Z01 SC 010354
|
$106,826
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Clinical Pharmacology of Anticancer Drugs
|
Z01 BC 011080
|
$936,285
|
Balis, Frank
|
CCR (NCI)
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-21S1
|
$27,801
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-21
|
$1,665,362
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology program Research Base
|
5U10CA095861-07
|
$1,984,870
|
POLLOCK, BRAD
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-25
|
$422,772
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Comparative Genomic Hybridization of Neuroblastoma
|
Z01 BC 010592
|
$40,782
|
Khan, Javed
|
CCR (NCI)
|
|
Consequences of receptor cross talk on inflammation and algesia
|
Z01 BC 010708
|
$54,812
|
Oppenheim, Joost
|
CCR (NCI)
|
|
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies
|
5U01CA105695-05
|
$146,647
|
CLOUGHESY, TIMOTHY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes
|
Z01 BC 010734
|
$37,561
|
Hornyak, Thomas
|
CCR (NCI)
|
|
Determinants of Melanocyte Transformation and Melanoma Progression
|
Z01 BC 010565
|
$300,493
|
Hornyak, Thomas
|
CCR (NCI)
|
|
Determining the Fate of Transmembrane Proteins
|
Z01 BC 009392
|
$621,480
|
Weissman, Allan
|
CCR (NCI)
|
|
Development of Mouse Astrocytoma Model for Preclinical Testing
|
Z01 BC 010541
|
$87,292
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other Ge
|
Z01 BC 010801
|
$427,304
|
Widemann, Brigitte
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|